Trade iShares Gold Trust Micro - IAUM CFD

Trading Conditions

• Type: CFD
• Spread: 0.11
• Long position overnight funding adjustment: -0.02149%
• Short position overnight funding adjustment: -0.00074%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 1
• Margin: 5.00%
• Stock exchange: United States of America
• Commission on trade: 0%
• Guaranteed stop premium: 1%

Key Stats

• Prev. Close: 43.8
• Open: 45.48
• 1-Year Change: 0.69%
• Day's Range: 44.89 - 45.52

What is iShares Gold Trust Micro (IAUM)?

iShares Gold Trust Micro is an exchange-traded fund that seeks to reflect the performance of the price of gold. The fund provides investors with a means to gain exposure to the gold market without the need to directly purchase and store physical gold. It holds physical gold bullion as its primary asset, aiming to track the spot price of gold minus expenses. The trust offers a convenient and cost-effective way for investors to diversify their portfolios with a commodity that is often viewed as a hedge against inflation and currency fluctuations. It is part of a broader suite of precious metals investment products.

iShares Gold Trust Micro Stock Price Today: Live Overview

The price today is shaped by the fluctuations in trading for Perspective Therapeutics Inc, currently at $45.00. The price has shifted between $45.03 and $45.58, marking a daily change of +3.1514%.

FAQ: iShares Gold Trust Micro (IAUM)

What is the current price of IAUM stock?

The current trading price is $45.00.

Does IAUM pay dividends?

The fund does not pay dividends.

Does IAUM have a formal corporate presence or regional headquarters in the UAE?

iShares Gold Trust Micro does not have a physical presence in the UAE and operates through local financial intermediaries.

What is IAUM best known for?

It is most famous for providing investors exposure to gold through an exchange-traded product.

What assets are typically shown together with IAUM?

Commonly shown alongside IAUM: Columbia EM Core ex-China ETF, CorMedix, Thomson Reuters